During treatment, providers may continue evaluating progress, discuss symptoms, review treatment goals, and determine whether any changes are appropriate based on the patients clinical response
It is characterized by rapid progression, a poor prognosis, and early metastasis
Synergistic Protocols & Adjuncts Triple-Support Regimen Morning: PQQ 20 mg + CoQ10 (ubiquinol) 100 mg Midday: ALA 300 mg Evening: CoQ10 100 mg + ALA 300 mg Lifestyle Synergies Exercise: Endurance and resistance training upregulate PGC-1, amplifying PQQs biogenic effects
Surgery involves considerable preparation, general anesthesia, the risk of infection, pain in the affected areas, and a lengthy recovery period
Digestive conditions Some medical conditions can interfere with the bodys ability to absorb B-12 from food